Mosquito
Mosquito-borne diseases are currently most prevalent in East Africa, Latin America,  Southeast Asia, and India; however, emergence of vector-borne diseases in Europe have recently been observed. A weighted risk analysis demonstrated associations to climate for 49% of infectious diseases in Europe including all transmission routes. One statistical model predicts by 2030, the climate of southern Great Britain will be climatically-suitable for malaria transmission "Plasmodium vivax" malaria for 2 months of the year. By 2080 it is predicted that the same will be true for southern Scotland.
Genetically modified organism
Fungi, being the most common pathogens of insects, make attractive biopesticides. Unlike bacteria and viruses they have the advantage of infecting the insects by contact alone, although they are out competed in efficiency by chemical pesticides. Genetic engineering can improve virulence, usually by adding more virulent proteins, increasing infection rate or enhancing spore persistence. Many of the disease carrying vectors are susceptible to entomopathogenic fungi. An attractive target for biological control are mosquitos, vectors for a range of deadly diseases, including malaria, yellow fever and dengue fever. Mosquitos can evolve quickly so it becomes a balancing act of killing them before the "Plasmodium" they carry becomes the infectious disease, but not so fast that they become resistant to the fungi. By genetically engineering fungi like "Metarhizium anisopliae" and "Beauveria bassiana" to delay the development of mosquito infectiousness the selection pressure to evolve resistance is reduced. Another strategy is to add proteins to the fungi that block transmission of malaria or remove the "Plasmodium" altogether.